G. Kloecker

C. Love, E. Hirschowitz, G. Kloecker, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Omar H. Butt, Alokkumar Jha, M. Bonnen, 2020, Cancer Cell.

Dectin-1 Activation by a Natural Product

Xiaoling Hu, R. Higashi, A. N. Lane, 2015 .

Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer

N. Dunlap, G. Kloecker, S. Bhandari, 2020, Journal of thoracic disease.

Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature

M. Bousamra, G. Kloecker, Diana M. Haninger, 2014, Modern Pathology.

Targeting of Antigens to B Lymphocytes via CD19 as a Means for Tumor Vaccine Development

Xiaoling Hu, Guoxin Li, Huang-Ge Zhang, 2013, The Journal of Immunology.

A phase 2, open-label, multi-center study of amuvatinib in combination with platinum etoposide chemotherapy in platinum-refractory small cell lung cancer patients

M. Krzakowski, T. Owonikoko, J. Fujimoto, 2017, Oncotarget.

The role of alectinib in the treatment of advanced ALK-rearranged non-small-cell lung cancer

G. Kloecker, C. Perez, Srividya Srinivasamaharaj, 2016, Expert review of anticancer therapy.

Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer.

Xiaoling Hu, Satoru Takahashi, E. Rouchka, 2020, The Journal of clinical investigation.

CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis

Praveen Kumar Sharma, Shailesh Singh, J. Lillard, 2014, Oncotarget.

Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer.

G. Kloecker, A. Jenson, J. Joh, 2010, Experimental and molecular pathology.

Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond

G. Kloecker, C. Perez, A. Paintal, 2015, OncoTargets and therapy.

Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.

Y. Iwakura, Jun Yan, C. Ding, 2011, Blood.

Rescue therapy for acute idiopathic thrombocytopenic purpura unresponsive to conventional treatment

G. Kloecker, S. Reynolds, Hamza Hashmi, 2019, BMJ Case Reports.

The Role of Human Papilloma Virus in Lung Cancer: A Review of the Evidence

Arash Rezazadeh, Goetz Kloecker, G. Kloecker, 2009, The American journal of the medical sciences.

A Phase I study of thalidomide, Capecitabine and temozolomide in advanced cancer

G. Kloecker, D. Laber, C. Salvador, 2007, Cancer biology & therapy.

Metabolic profiling identifies lung tumor responsiveness to erlotinib.

A. Lane, T. Fan, R. Higashi, 2009, Experimental and molecular pathology.

Phase II Trial on Extending the Maintenance Flushing Interval of Implanted Ports.

S. Rai, G. Kloecker, J. Chao, 2017, Journal of oncology practice.

The Hispanic paradox in non-small cell lung cancer.

G. Kloecker, S. Bhandari, Rohit Kumar, 2021, Hematology/oncology and stem cell therapy.

Extended phase I study of AS1411 in renal and non-small cell lung cancers.

P. Bates, J. Trent, G. Kloecker, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lung cancer screening: from imaging to biomarker

K. Shen, G. Kloecker, C. Freter, 2013, Biomarker Research.

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer.

G. Giaccone, D. Dunlop, J. Nemunaitis, 2015, European journal of cancer.

Lung cancer screening: from imaging to biomarker

K. Shen, G. Kloecker, C. Freter, 2013, Biomarker Research.

Differential scanning calorimetry of blood plasma for lung cancer diagnosis.

J. Chaires, N. Garbett, G. Kloecker, 2010 .

Plasma thermogram profiling: A novel biomarker for lung cancer.

J. Chaires, N. Garbett, G. Kloecker, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Utility of Differential Scanning Calorimetry Curves of Blood Plasma for Diagnosis, Subtype Differentiation and Predicted Survival in Lung Cancer

M. Merchant, Daniel W. Wilkey, N. Garbett, 2021, Cancers.

A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma

K. McMasters, Donald M Miller, G. Kloecker, 2006, Journal of Cancer Research and Clinical Oncology.

Racial differences in development of immune-related adverse events.

G. Kloecker, S. Bhandari, Rohit Kumar, 2020 .

Fixed-Dose Every-Other-Week Capecitabine and Oxaliplatin for Refractory Squamous Cell Carcinoma of the Head and Neck

Donald M Miller, G. Kloecker, G. Rabinowits, 2010, The American journal of the medical sciences.

Phase II trial of second-line erlotinib and digoxin in patients with non-small cell lung cancer (NSCLC).

G. Kloecker, F. Kayali, D. Miller, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Integration of Multimodality Care for the Treatment of Small Cell Lung Cancer in a Rural Population and Its Impact on Survival

S. Rai, N. Dunlap, Jianmin Pan, 2015, American journal of clinical oncology.

CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases

Shailesh Singh, J. Lillard, Rajesh Singh, 2015, Oncotarget.

Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer

Xiaoling Hu, M. Bousamra, Sabrin H Albeituni, 2016, The Journal of Immunology.

Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.

N. Dunlap, G. Kloecker, C. Silverman, 2015, Experimental and molecular pathology.

The association between history of traumatic events and health-related quality of life among lung cancer patients

E. Cash, P. Salmon, René Bayley-Veloso, 2020, Journal of psychosocial oncology.

Differentiation to APC in Cancer Apoptosis and Monocytic MDSC by Inducing Polymorphonuclear MDSC Myeloid-Derived Suppressor Cells ( MDSC ) Treatment Subverts the Suppression of-Glucan β Yeast-Derived Particulate

Xiaoling Hu, M. Bousamra, Huang-Ge Zhang, 2016 .

Timing of treatment in small-cell lung cancer

G. Kloecker, C. Pinkston, S. Bhandari, 2019, Medical Oncology.

Radon and lung cancer.

M. El-Ghamry, G. Kloecker, Tarsheen K Sethi, 2012, Clinical advances in hematology & oncology : H&O.

Aside from increasing the risk of lung cancer in smokers , radon is an independent risk factor in nonsmokers . Recognition of the Radon and Lung Cancer

M. El-Ghamry, G. Kloecker, Tarsheen K Sethi, 2012 .

Patient perceptions concerning clinical trials in oncology patients

G. Kloecker, D. Lee, J. Chao, 2016, Contemporary clinical trials communications.

Thrombotic Thrombocytopenic Purpura Associated With Hodgkin Lymphoma

G. Kloecker, J. Chao, 2013 .

Lung Cancer Screening Registry Reveals Low-dose CT Screening Remains Heavily Underutilized.

G. Kloecker, C. Pinkston, S. Bhandari, 2019, Clinical lung cancer.

Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non–Small Cell Lung Cancer

N. Dunlap, S. Woo, G. Kloecker, 2016, American journal of clinical oncology.

Treatment and outcomes of non-small-cell lung cancer patients with high comorbidity

Bin Huang, G. Kloecker, T. Tucker, 2018, Cancer management and research.

Consolidation nivolumab/ipilimumab versus nivolumab following concurrent chemoradiation in patients with unresectable stage III NSCLC: A planned interim safety analysis from the BTCRC LUN 16-081 trial.

N. Hanna, S. Jabbour, J. Naidoo, 2020 .

Pemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer

M. Socinski, R. Kurek, Michael Thomas, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Venous and arterial thromboembolism with immunotherapy compared to platinum-based therapy.

A. Rojan, G. Kloecker, J. Chesney, 2022, Thrombosis Research.

Effect of zoledronic acid on tartrate-resistant acid phosphatase isoform type 5b and other bone markers in lung cancer patients with bone metastases

G. Kloecker, G. Rabinowits, D. Laber, 2012 .

Expression and clinical significance of CXCR5/CXCL13 in human non-small cell lung carcinoma

Shailesh Singh, J. Lillard, Rajesh Singh, 2014, International journal of oncology.

Urinary Incontinence among Male Veterans Receiving Care in Primary Care Clinics

G. Kloecker, S. Smoger, Toni L Felice, 2000, Annals of Internal Medicine.

P1.18-05 ChemoXRT W/ Consolidation Pembrolizumab in Unresectable Stage III NSCLC: Long-Term Survival Update and Analysis of Post-Progression Therapy

N. Hanna, S. Jalal, R. Zon, 2019, Journal of Thoracic Oncology.

The quality of medical evidence in hematology-oncology.

B. Djulbegovic, E. Efthimiadis, C. Hornung, 1999, The American journal of medicine.

Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma

Philip S. Yu, Sharon S. Choi, Omar H. Butt, 2023, BMC Cancer.

15 – Nanotube- and graphene-based photomedicine for cancer therapeutics

E. Wickstrom, B. Panchapakesan, Farhad Khosravi, 2015 .

Interim safety analysis of consolidation nivolumab and ipilimumab versus nivolumab alone following concurrent chemoradiation for unresectable stage IIIA/IIIB NSCLC: Big Ten Cancer Research Consortium LUN 16-081.

N. Hanna, A. Ganti, S. Jabbour, 2019, Journal of Clinical Oncology.

OA01.07 Updated Results of a Phase II Trial of Concurrent Chemoradiation with Consolidation Pembrolizumab in Patients with Unresectable Stage III NSCLC

N. Hanna, S. Jalal, R. Zon, 2018, Journal of Thoracic Oncology.

Performance of community-based lung cancer screening program in a Histoplasma endemic region.

G. Kloecker, C. Pinkston, S. Bhandari, 2019, Lung cancer.

Static micro-array isolation, dynamic time series classification, capture and enumeration of spiked breast cancer cells in blood: the nanotube–CTC chip

S. Rai, E. Wickstrom, B. Panchapakesan, 2016, Nanotechnology.

Transient and Spontaneous Idiopathic Factor V Inhibitor

G. Kloecker, D. Laber, L. Bhupalam, 2008 .

Safety and feasibility of consolidation pembrolizumab following concurrent chemoradiation for unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN14-179.

Cynthia S. Johnson, N. Hanna, S. Jalal, 2017 .

Obtaining Routine Blood Cultures During Interleukin-2-Containing Therapy Is Unnecessary

F. Arnold, G. Kloecker, J. Chesney, 2009, American journal of clinical oncology.

Phase II trial of concurrent chemoradiation with consolidation pembrolizumab in patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179.

N. Hanna, S. Jalal, R. Zon, 2018 .

Tumor Treating Field (TTFields) therapy with standard of care (SOC) in metastatic non-small cell lung cancer (mNSCLC) following platinum failure: Randomized, phase 3 LUNAR study.

J. Milanowski, J. Aerts, R. Ramlau, 2023, Journal of Clinical Oncology.

Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond

G. Kloecker, Graham, C. Perez, 2015, OncoTargets and therapy.

Cellular Therapy for Lung Cancer: Focusing on Chimeric Antigen Receptor T (CAR T) Cells and Tumor-Infiltrating Lymphocyte (TIL) Therapy

G. Kloecker, J. Chesney, Vatsala Katiyar, 2023, Cancers.

Nanotube Devices for Digital Profiling: A focus on cancer biomarkers and circulating tumor cells.

E. Wickstrom, B. Panchapakesan, Farhad Khosravi, 2013, IEEE Nanotechnology Magazine.

Nanotube devices for digital profiling of cancer biomarkers and circulating tumor cells

E. Wickstrom, B. Panchapakesan, Farhad Khosravi, 2013, The 7th IEEE International Conference on Nano/Molecular Medicine and Engineering.

Electrical detection of specific versus non-specific binding events in breast cancer cells

Balaji Panchapakesan, Palaniappan Sethu, Benjamin C. King, 2012, Optics & Photonics - NanoScience + Engineering.

Nanotube Devices for Digital Profiling

E. Wickstrom, B. Panchapakesan, Farhad Khosravi, 2014 .

Abstract 2095: A phase 2 study of Amuvatinib (MP-470), the first RAD51 inhibitor in combination with platinum-etoposide (PE) in refractory or relapsed small cell lung cancer (ESCAPE).

M. Krzakowski, T. Owonikoko, L. Byers, 2013 .

Survey of Primary Care Physicians on Therapeutic Approaches to Lung and Breast Cancers

Jianmin Pan, G. Kloecker, J. Alexander, 2014, Southern medical journal.

Radon and lung cancer.

M. El-Ghamry, G. Kloecker, Tarsheen K Sethi, 2012, Clinical advances in hematology & oncology : H&O.

Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study.

R. Greil, J. Milanowski, J. Aerts, 2023, The Lancet. Oncology.

Classification of biosensor time series using dynamic time warping: applications in screening cancer cells with characteristic biomarkers

Balaji Panchapakesan, Shesh N Rai, Goetz Kloecker, 2016, Open access medical statistics.

Correction: Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer

Xiaoling Hu, M. Bousamra, Sabrin H Albeituni, 2016, The Journal of Immunology.

The Role of Human Papilloma Virus in Lung Cancer: A Review of the Evidence

G. Kloecker, S. Ghim, D. Laber, 2009, The American journal of the medical sciences.

Evaluating patterns of failure and salvage therapy for patients treated with primary stereotactic body radiation therapy for early stage non-small cell lung cancer

M. Bousamra, N. Dunlap, G. Kloecker, 2014 .